Every healthcare marketing team has had this conversation at least once: the campaign report shows a great cost-per-lead, the pipeline dashboard shows almost nothing moving, and nobody can quite explain the gap. The instinct is to blame sales follow-up, timing, or "market conditions." Increasingly, the more honest answer is that cost-per-lead was never measuring the thing anyone actually cared about.
That gap is why a growing number of data and marketing ops teams — particularly in healthcare, where contact turnover is brutal and compliance stakes are high — are quietly shifting how they evaluate list and lead spend. The metric gaining ground isn't a replacement buzzword; it's a more honest denominator: cost-per-verified-contact instead of cost-per-lead.
The Comfortable Lie of Cost-Per-Lead
Cost-per-lead is popular because it's simple and it's cheap to report well. A lead is anyone who filled out a form, got scraped into a list, or matched a firmographic filter. Nothing about that definition requires the contact to still work there, still hold that title, or even have a working email address. Which means cost-per-lead can look fantastic while the underlying list is quietly decaying.
This is especially true in healthcare data, where role churn is high — practice consolidations, provider moves between systems, credentialing changes, and department reorganizations all mean a contact record can be accurate on Monday and stale by the following quarter. A vendor or internal list that was compiled six months ago can hit inboxes at a bounce rate that would embarrass anyone, but the original cost-per-lead number never adjusts for that. It was locked in at the moment of "lead," not at the moment of actual, working contact.
What's happening industry-wide is that teams are starting to notice the pattern: campaigns with excellent cost-per-lead numbers are producing mediocre reply rates, and campaigns with worse cost-per-lead numbers — because the source did more verification up front — are outperforming on actual engagement. Once that pattern shows up two or three times, people stop trusting the headline number.
What Verification Actually Buys You (and What It Doesn't)
The appeal of cost-per-verified-contact isn't that verification makes a list morally superior. It's that it moves the cost of finding out a record is dead from after the campaign to before it. Every list has some rate of decay — the question is only whether you pay for that decay in wasted sends and lost rep hours, or whether you pay for it upfront as part of acquisition cost.
This is where the math actually gets interesting, and where a lot of teams get it wrong in both directions. Some assume verified contacts are simply "more expensive leads" and resist the higher sticker price without doing the follow-through math. Others assume verification is a silver bullet and stop scrutinizing the source entirely once a vendor says "verified."
Neither is right. Verified contact cost needs to be compared against the fully loaded cost of an unverified lead — including the SDR time spent dialing disconnected numbers, the email infrastructure damage from hard bounces, and the compliance exposure of contacting someone at an address tied to a health system they no longer work for. When healthcare marketing teams actually run this comparison, the "cheap" lead list often turns out to be the more expensive option once you count everything downstream of the CRM import.
That said, verification has limits worth being skeptical about. Verified at what date? Verified against what — deliverability only, or role and location too? A contact whose email pings clean but whose title changed eight months ago is "verified" in one sense and useless in another. This is the detail a lot of vendor pitches gloss over, and it's worth pressing on before treating cost-per-verified-contact as a clean, trustworthy number itself.
Why Sales and Marketing Keep Disagreeing About Which Number Matters
Part of why this shift is slower than it should be is organizational, not technical. Marketing is often measured on volume and cost-per-lead because those numbers are easy to report up the chain and easy to hit targets against. Sales teams, meanwhile, are the ones who actually feel the cost of bad contacts — the wasted calls, the CRM clutter, the reps who quietly stop trusting inbound lists altogether. That disconnect means the metric that looks good in the marketing dashboard is often the same one sales privately regards as unreliable.
It's becoming common for revenue ops teams to sit in the middle of this argument and push for a shared metric that both sides can defend, and cost-per-verified-contact is increasingly the compromise. It doesn't ignore volume — you still want a healthy number of contacts — but it forces a conversation about quality thresholds before the number gets celebrated. Some organizations are going further and tying rep compensation or pipeline credit only to contacts that clear a verification bar, which changes behavior fast: sourcing teams stop optimizing purely for cheap volume once cheap volume stops counting.
This is also where companies working in healthcare data — NPLUS Global among them — have had to adjust how they talk about pricing with clients, because a buyer asking "what's your cost per lead" is often really asking a question they haven't finished forming yet. The more useful conversation is about cost per contact that's actually reachable, current, and relevant to the buying committee in question.
Where This Is Heading
The direction of travel is fairly clear. As list decay becomes harder to ignore and sales teams get more vocal about wasted outreach, cost-per-lead is going to keep losing credibility as a standalone metric — not because it's fake, but because it measures acquisition, not usability. Cost-per-verified-contact isn't perfect, and it shouldn't be treated as automatically trustworthy just because it sounds more rigorous. But it asks a better question: not "how much did it cost to get a name," but "how much did it cost to get a name we can actually use."
Teams that make this shift early aren't just improving their reporting — they're forcing an earlier, harder conversation about what a "lead" is supposed to mean in the first place. That's an uncomfortable conversation for anyone whose numbers currently look good under the old definition. It's probably the right one to have anyway.
Ready to see what we can build for your ICP?
Send us your ICP — sample in 2–3 hours, full delivery in 48–72 hours.
Request a free sample →